Diaceutics PLC
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DIUXF research report →
Price Chart
About the company
Diaceutics PLC operates as a global diagnostic commercialization entity, providing pharmaceutical companies worldwide with essential data, sophisticated analytics, and implementation support. Central to its offerings is the DXRX platform, a comprehensive suite designed to address various aspects of precision medicine. This platform delivers: DXRX Data Solutions: Granting access to a vast network of laboratory diagnostic testing data.
- CEO
- Ryan Keeling
- IPO
- 2020
- Employees
- 205
- HQ
- Belfast, AT, GB
Get TickerSpark's AI analysis on DIUXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $195.16M
- P/E
- -637.50
- Fwd P/E
- 191.77
- PEG
- 0.91
- P/S
- 4.18
- P/B
- 4.46
- EV/EBITDA
- 30.16
- Div Yield
- 0.00%
- Gross Margin
- 67.81%
- Op Margin
- -2.28%
- Net Margin
- -0.66%
- ROE
- -0.68%
- ROIC
- -1.02%
Latest fiscal year · YoY change
- Revenue
- $38.43M+19.5%
- Gross Profit
- $25.66M-9.2%
- Op Income
- $-211,965
- Net Income
- $96.98K+105.7%
- EPS
- $0.00+105.9%
- OCF Growth
- +129.8%
- FCF Growth
- +135.8%
- 52W High
- $2.51
- 52W Low
- $1.37
- 50D MA
- $2.07
- 200D MA
- $1.84
- Beta
- 0.89
- RSI (14)
- 100
- Avg Volume
- 54
No earnings-call transcripts are available for DIUXF yet.
- Free Float
- 57.5%
- Shares Outstanding
- 84.63M
- Float Shares
- 48.68M
Our DIUXF coverage
Recent articles, reports, and earnings notes.
No research on DIUXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DIUXF report →